VGLL4 enhances PDK4 transcription and promotes metabolic dysfunction-associated fatty liver disease.

Chen Y, Wang X, Yu W, Gong M, Lu Y, Xu J, Zhang H, Yang R, Zhang H, Gao H, Gao Z, Yan J, Jiang Z, Zhang S, Ma X, Yu J, Wei F, Fu Q, Zhou Y, Zhou J, Wan J, Jin Y, Zhang L

Open source

DOI
10.1038/s44319-026-00934-x
Published
2026 Sep 22
Container
EMBO reports
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s44319-026-00934-x,
  title = {VGLL4 enhances PDK4 transcription and promotes metabolic dysfunction-associated fatty liver disease.},
  author = {Chen Y and Wang X and Yu W and Gong M and Lu Y and Xu J and Zhang H and Yang R and Zhang H and Gao H and Gao Z and Yan J and Jiang Z and Zhang S and Ma X and Yu J and Wei F and Fu Q and Zhou Y and Zhou J and Wan J and Jin Y and Zhang L},
  year = {2026},
  journal = {EMBO reports},
  doi = {10.1038/s44319-026-00934-x},
  url = {https://doi.org/10.1038/s44319-026-00934-x}
}

RIS

TY  - JOUR
TI  - VGLL4 enhances PDK4 transcription and promotes metabolic dysfunction-associated fatty liver disease.
AU  - Chen Y
AU  - Wang X
AU  - Yu W
AU  - Gong M
AU  - Lu Y
AU  - Xu J
AU  - Zhang H
AU  - Yang R
AU  - Zhang H
AU  - Gao H
AU  - Gao Z
AU  - Yan J
AU  - Jiang Z
AU  - Zhang S
AU  - Ma X
AU  - Yu J
AU  - Wei F
AU  - Fu Q
AU  - Zhou Y
AU  - Zhou J
AU  - Wan J
AU  - Jin Y
AU  - Zhang L
PY  - 2026
JO  - EMBO reports
DO  - 10.1038/s44319-026-00934-x
UR  - https://doi.org/10.1038/s44319-026-00934-x
ER  - 

APA

Y, C., X, W., W, Y., M, G., Y, L., J, X., H, Z., R, Y., H, Z., H, G., Z, G., J, Y., Z, J., S, Z., X, M., J, Y., F, W., Q, F., Y, Z., J, Z., J, W., Y, J., & L, Z. (2026). VGLL4 enhances PDK4 transcription and promotes metabolic dysfunction-associated fatty liver disease.. EMBO reports. https://doi.org/10.1038/s44319-026-00934-x

Source records